S'abonner

5.0T MRA techniques for evaluating Moyamoya disease: 4D-ASL-MRA vs. 3D-TOF-MRA - 29/10/25

Doi : 10.1016/j.neurad.2025.101376 
Shi-hai Zhao a, 1, Yuan-ren Zhai b, c, d, e, 1, Yi-jun Zhou a, Gan Sun f, Ke Xue g, Hua-lu Han h, Dong Wang h, Yu-xin Yang g, Ming-li Li a, Jun Ni i, Dong Zhang b, c, d, e, , Yi-ning Wang a, , Feng Feng a
a Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China 
b Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China 
c China National Clinical Research Center for Neurological Diseases, Beijing, China 
d Department of Neurosurgery, Beijing Hospital, National Center of Gerontology, Beijing, China 
e Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China 
f Theranostics and Translational Research Center, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 
g United Imaging Research Institute of Intelligent Imaging, Beijing, China 
h United Imaging Healthcare, Shanghai, China 
i Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 

Corresponding author at: Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Address: No.1, Shuaifuyuan, Dongcheng District, Beijing 100730, China.Department of RadiologyState Key Laboratory of Complex Severe and Rare DiseasesPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeAddress: No.1, ShuaifuyuanDongcheng DistrictBeijing100730China⁎⁎Co-corresponding author at: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.Department of NeurosurgeryBeijing Tiantan HospitalCapital Medical UniversityBeijingChina

Graphical abstract




Image, graphical abstract

Le texte complet de cet article est disponible en PDF.

Highlights

4D-ASL-MRA at 5.0T better visualizes terminal ICAs, stenosis, and collaterals than 3D-TOF-MRA.
4D-ASL-MRA matches DSA in Moyamoya staging (κ=0.88), surpassing 3D-TOF-MRA (κ=0.57).
4D-ASL-MRA dynamically tracks blood flow, revealing collateral patterns 3D-TOF-MRA cannot.

Le texte complet de cet article est disponible en PDF.

Abstract

Purpose

Three-dimensional time-of-flight MR-angiography (3D-TOF-MRA) at 5.0T showed comparable capacity to 7.0T for visualizing small vessels, but has not yet been compared with arterial spin labeling (ASL)-based four-dimensional MR-angiography (4D-ASL-MRA) at 5.0T. This study aimed to compare the performance of these two MRA techniques at 5.0T in evaluating Moyamoya disease (MMD).

Methods

This retrospective study included 20 consecutive MMD patients who underwent 4D-ASL-MRA with six labeling times (100 ms to 1800 ms) and 3D-TOF-MRA at 5.0T Analyses included Suzuki grades, contrast-to-noise ratio (CNR), number of branches in middle cerebral artery (MCA), and image scores of terminal internal carotid arteries (ICA), stenosis around terminal ICA, distal MCA, Moyamoya vessels, and leptomeningeal anastomosis (LMA) collateral vessels.

Results

Twenty patients (10 females, 33 ± 8 years) with 30 cerebral hemispheres were analyzed. Compared to 3D-TOF-MRA, 4D-ASL-MRA with 900 ms to 1800 ms labeling times demonstrated superior visualization scores for terminal ICA, stenosis around terminal ICA, and LMA (4D-ASL-MRA with 900 ms vs 3D-TOF-MRA: 4.00 ± 0.00 vs 3.50 ± 0.68, 3.00 ± 0.00 vs 2.68 ± 0.55, 2.37 ± 1.19 vs 1.40 ± 0.97, respectively, all p < 0.05), and 4D-ASL-MRA at 1800 ms showed higher CNR in the M4 segment (45.84 ± 20.28 vs 27.54 ± 24.46, p < 0.001) but lower in M1 to M3 segments (65.61 ± 36.22 vs 173.58 ± 148.25, 48.89 ± 29.44 vs 122.86 ± 104.23, 44.68 ± 30.05 vs 78.36 ± 72.64, respectively, all p < 0.05) and more visible distal MCA branches (24.83 ± 5.49 vs 15.03 ± 5.99, p < 0.001). The inter-modality agreement on Suzuki grades between 4D-ASL-MRA and digital subtraction angiography (DSA) was excellent (κ= 0.88), outperforming that between 3D-TOF-MRA and DSA (κ= 0.57).

Conclusion

At 5.0T, 4D-ASL-MRA demonstrated superior visualization of terminal ICA, distal MCA, and collateral vessels in MMD, as well as staging MMD more accurately than 3D-TOF-MRA.

Le texte complet de cet article est disponible en PDF.

Keywords : Moyamoya disease, Ultra-high field, MR-angiography

Abbreviation list : MMD, 4D-ASL-MRA, 3D-TOF-MRA, MCA, ICA, LMA, UHF, CNR


Plan


© 2025  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 52 - N° 6

Article 101376- novembre 2025 Retour au numéro
Article précédent Article précédent
  • Distal vessel aspiration (DIVA) with the RED 043 catheter in acute ischaemic stroke
  • Vinicius Carraro do Nascimento, Strahan Teoh, Permesh Singh Dhillon, Laetitia de Villiers, Hal Rice
| Article suivant Article suivant
  • Intraoperative and long-term multimodal radiological assessment of brain MR-guided laser interstitial thermal therapy (MRgLITT) in children
  • Alice Hu, Lelio Guida, Ludovic Fillon, Rima Nabbout, François Doz, Oumaima Aboubakr, Thomas Blauwblomme, Nathalie Boddaert, Volodia Dangouloff-Ros

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.